Mark Robert Baker Insider Profile
4 Followers
Mark Robert Baker, former CEO, Director at Progenics, holds 161.14K shares in Progenics (Ticker: PGNX).
Mark Robert Baker's Trading History
| PGNXProgenics | Mar 28, 2013 | ― | Uninformative Buy | 3.46K | $660.68K | |
PGNX | ||||||
You May Also Like
Mark Robert Baker insider profile FAQ
What is the percentage of profitable transactions made by Mark Robert Baker?
The percentage of profitable transactions made by Mark Robert Baker is 75%.
What is the average return per transaction made by Mark Robert Baker?
The average return per transaction made by Mark Robert Baker is 63.70%.
What stocks does Mark Robert Baker hold?
Mark Robert Baker holds: PGNX stocks.
What was Mark Robert Baker’s latest transaction?
Mark Robert Baker’s latest transaction was an Uninformative Buy of $3.46K.
What was Mark Robert Baker's most profitable transaction?
Mark Robert Baker’s most profitable transaction was an Informative Buy of PGNX stock on November 16, 2012. The return on the trade was 106.90%.
What is Mark Robert Baker's role in Progenics?
Mark Robert Baker's role in Progenics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
